Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Bullboard Post History

by SophiaBrown


GE

Kevin Harrington Discusses FSD Pharma

{^youtubevideo|(width)560|(height)340|(rel)False|(url)https://www.youtube.com...

April 13, 2023

AAL

Kevin Harrington Discusses FSD Pharma

{^youtubevideo|(width)560|(height)340|(rel)False|(url)https://www.youtube.com...

April 13, 2023

F

Kevin Harrington Discusses FSD Pharma

{^youtubevideo|(width)560|(height)340|(rel)False|(url)https://www.youtube.com...

April 13, 2023

F

FSD Pharma Subsidiary Lucid Psycheceuticals Files for Patent

FSD Pharma Subsidiary Lucid Psycheceuticals Files for Patent On Novel...

July 13, 2022

AAL

FSD Pharma Subsidiary Lucid Psycheceuticals Files for Patent

FSD Pharma Subsidiary Lucid Psycheceuticals Files for Patent On Novel...

July 13, 2022

GE

FSD Pharma Subsidiary Lucid Psycheceuticals Files for Patent

FSD Pharma Subsidiary Lucid Psycheceuticals Files for Patent On Novel...

July 13, 2022

F

FSD will proceed with Phase2 of FSD-201 soon after clearance

{^youtubevideo|(width)560|(height)340|(rel)False|(url)https://www.youtube.com...

June 3, 2022

AAL

FSD will proceed with Phase2 of FSD-201 soon after clearance

{^youtubevideo|(width)560|(height)340|(rel)False|(url)https://www.youtube.com...

June 3, 2022

GE

FSD will proceed with Phase2 of FSD-201 soon after clearance

{^youtubevideo|(width)560|(height)340|(rel)False|(url)https://www.youtube.com...

June 3, 2022

GE

FSD Pharma Files Investigational New Drug Application (“IND”

  FSD Pharma Files Investigational New Drug Application (“IND”) with...

June 1, 2022

AAL

FSD Pharma Files Investigational New Drug Application (“IND”

  FSD Pharma Files Investigational New Drug Application (“IND”) with...

June 1, 2022

F

FSD Pharma Files Investigational New Drug Application (“IND”

  FSD Pharma Files Investigational New Drug Application (“IND”) with...

June 1, 2022

F

FSD Pharma Closes CAD$16.4 Million Sale of Non-Core Assets

FSD Pharma Closes CAD$16.4 Million Sale of Non-Core Assets   Nets...

May 10, 2022

AAL

FSD Pharma Closes CAD$16.4 Million Sale of Non-Core Assets

FSD Pharma Closes CAD$16.4 Million Sale of Non-Core Assets   Nets...

May 10, 2022

GE

FSD Pharma Closes CAD$16.4 Million Sale of Non-Core Assets

FSD Pharma Closes CAD$16.4 Million Sale of Non-Core Assets  ...

May 10, 2022

F

Lucid-MS for Multiple Sclerosis Treatment

{^youtubevideo|(width)560|(height)340|(rel)False|(url)https://www.youtube.com...

May 3, 2022

AAL

Lucid-MS for Multiple Sclerosis Treatment

{^youtubevideo|(width)560|(height)340|(rel)False|(url)https://www.youtube.com...

May 1, 2022

GE

Lucid-MS for Multiple Sclerosis Treatment

{^youtubevideo|(width)560|(height)340|(rel)False|(url)https://www.youtube.com...

April 30, 2022

F

"Julia Levy Award" Recipient David Allan and Dr. John McGraw

FSD Pharma Appoints Julia Levy Award Recipient David Allan and Dr. John...

April 25, 2022

AAL

"Julia Levy Award" Recipient David Allan and Dr. John McGraw

FSD Pharma Appoints Julia Levy Award Recipient David Allan and Dr. John...

April 23, 2022

1 2 3 4 5 6 7 8 Next